Free Trial

Fevertree Drinks (LON:FEVR) Insider Buys £477,400 in Stock

Fevertree Drinks logo with Consumer Defensive background

Key Points

  • Kevin Havelock, an insider at Fevertree Drinks, purchased £477,400 worth of stock by buying 55,000 shares at an average cost of GBX 868 each on October 16th.
  • Equities analysts have varied projections for Fevertree Drinks' stock price, with forecasts ranging from GBX 800 to GBX 1,100, and an average target price of GBX 930.
  • Fevertree Drinks reported a quarterly EPS of GBX 6.85 and has a market capitalization of £1.02 billion, with significant trading activity observed recently.
  • Five stocks we like better than Fevertree Drinks.

Fevertree Drinks PLC (LON:FEVR - Get Free Report) insider Kevin Havelock bought 55,000 shares of the firm's stock in a transaction that occurred on Thursday, October 16th. The shares were acquired at an average cost of GBX 868 per share, with a total value of £477,400.

Kevin Havelock also recently made the following trade(s):

  • On Thursday, September 11th, Kevin Havelock bought 37,000 shares of Fevertree Drinks stock. The shares were acquired at an average cost of GBX 846 per share, with a total value of £313,020.

Fevertree Drinks Trading Down 0.5%

LON FEVR traded down GBX 4 during trading hours on Monday, hitting GBX 867. 241,622 shares of the company's stock were exchanged, compared to its average volume of 571,228. The stock has a 50-day simple moving average of GBX 855.80 and a 200 day simple moving average of GBX 864.43. Fevertree Drinks PLC has a 1-year low of GBX 608.50 and a 1-year high of GBX 1,020. The firm has a market cap of £1.02 billion, a price-to-earnings ratio of 40.93, a PEG ratio of -4.51 and a beta of 1.07. The company has a current ratio of 4.11, a quick ratio of 3.21 and a debt-to-equity ratio of 1.50.

Fevertree Drinks (LON:FEVR - Get Free Report) last announced its quarterly earnings data on Thursday, September 11th. The company reported GBX 6.85 EPS for the quarter. Fevertree Drinks had a return on equity of 9.30% and a net margin of 6.05%. On average, equities analysts forecast that Fevertree Drinks PLC will post 38.3184173 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Fevertree Drinks from GBX 800 to GBX 840 and gave the company a "buy" rating in a research note on Thursday, September 11th. Jefferies Financial Group raised Fevertree Drinks to a "buy" rating and raised their price objective for the company from GBX 900 to GBX 1,100 in a research note on Tuesday, October 14th. Finally, JPMorgan Chase & Co. raised their price objective on Fevertree Drinks from GBX 770 to GBX 850 and gave the company a "neutral" rating in a research note on Friday, September 12th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of GBX 930.

Read Our Latest Stock Analysis on FEVR

About Fevertree Drinks

(Get Free Report)

Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fevertree Drinks Right Now?

Before you consider Fevertree Drinks, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.

While Fevertree Drinks currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.